Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
![Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports](https://www.embopress.org/cms/asset/43890f5e-2f3e-4f45-bf71-d3cbbedc167d/embr202153865-fig-0001ev-m.jpg)
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
![Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/624c4ea0-ab75-4b1b-a222-4d4d27edee91/jmv27936-fig-0004-m.jpg)
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
![The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine](https://www.science.org/cms/asset/56e753c7-29f7-47b0-99d5-161a25ef8bf6/abf1906-f1.gif)
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine
![Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24963-3/MediaObjects/41467_2021_24963_Fig1_HTML.png)
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
![A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25331-x/MediaObjects/41467_2021_25331_Fig1_HTML.png)
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
![Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6ca7887f-d867-4d10-9e0e-bbea705c83a6/fx1_lrg.jpg)
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
![Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy](https://www.frontiersin.org/files/Articles/697876/fcimb-11-697876-HTML/image_m/fcimb-11-697876-g001.jpg)
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
![Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports](https://www.embopress.org/cms/asset/4997687c-d832-405e-80c8-6b4c3682ee8b/embr202153865-fig-0006-m.jpg)
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
![Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.2c00573/asset/images/medium/mt2c00573_0001.gif)
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
![SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21609-2/MediaObjects/41467_2021_21609_Fig1_HTML.png)
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
![PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3550aa8c-f5d2-438c-b6a9-f269e7d2878f/cam43331-fig-0001-m.jpg)